Cargando…
Structure-guided approach to modulate small molecule binding to a promiscuous ligand-activated protein
Ligand-binding promiscuity in detoxification systems protects the body from toxicological harm but is a roadblock to drug development due to the difficulty in optimizing small molecules to both retain target potency and avoid metabolic events. Immense effort is invested in evaluating metabolism of m...
Autores principales: | Lin, Wenwei, Huber, Andrew D., Poudel, Shyaron, Li, Yongtao, Seetharaman, Jayaraman, Miller, Darcie J., Chen, Taosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013835/ https://www.ncbi.nlm.nih.gov/pubmed/36848571 http://dx.doi.org/10.1073/pnas.2217804120 |
Ejemplares similares
-
Crystal structure of an atypical cobalamin riboswitch reveals RNA structural adaptability as basis for promiscuous ligand binding
por: Chan, Clarence W, et al.
Publicado: (2020) -
Promiscuous Ligands
por: McGovern, S.L.
Publicado: (2007) -
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology
por: Lamers, Christina, et al.
Publicado: (2021) -
How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape
por: Bardaro, Michael F., et al.
Publicado: (2009) -
Modulating FOXO3 transcriptional activity by small, DBD-binding molecules
por: Hagenbuchner, Judith, et al.
Publicado: (2019)